Want to join the conversation?
$TMO's Diagnostics and Healthcare end-market businesses performance in 3Q15 was pretty much similar to what it has seen in the 1H15 with growth in the low single digits. The key contributors in 3Q15 were its Clinical Diagnostics business and Healthcare market channel, which continue to grow well.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)